117 related articles for article (PubMed ID: 38462830)
1. Quantitative Comparison of Liver Volume, Proton Density Fat Fraction, and Time Burden between Automatic Whole Liver Segmentation and Manual Sampling MRI Strategies for Diagnosing Metabolic Dysfunction-associated Steatotic Liver Disease in Obese Patients.
Cao D; Yang Y; Li M; Liu Y; Yang D; Xu H; Lv H; Zhang Z; Zhang P; Jia X; Yang Z
Curr Med Imaging; 2024 Mar; ():. PubMed ID: 38462830
[TBL] [Abstract][Full Text] [Related]
2. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
[TBL] [Abstract][Full Text] [Related]
3. Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study.
Cao D; Li M; Liu Y; Jin H; Yang D; Xu H; Lv H; Liu J; Zhang P; Zhang Z; Yang Z
BMC Med Imaging; 2022 May; 22(1):92. PubMed ID: 35581577
[TBL] [Abstract][Full Text] [Related]
4. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
5. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
[TBL] [Abstract][Full Text] [Related]
6. Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison With MRI Proton Density Fat Fraction as Reference Standard.
Dillman JR; Thapaliya S; Tkach JA; Trout AT
AJR Am J Roentgenol; 2022 Nov; 219(5):784-791. PubMed ID: 35674351
[No Abstract] [Full Text] [Related]
7. Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters.
Yoo J; Joo I; Jeon SK; Park J; Yoon SH
Eur Radiol; 2024 Feb; ():. PubMed ID: 38393403
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of magnetic resonance imaging proton density fat fraction (MRI-PDFF), magnetic resonance spectroscopy (MRS), and two different histopathologic methods (artificial intelligence
Kim JW; Lee CH; Yang Z; Kim BH; Lee YS; Kim KA
Quant Imaging Med Surg; 2022 Nov; 12(11):5251-5262. PubMed ID: 36330193
[TBL] [Abstract][Full Text] [Related]
9. Automated hepatic steatosis assessment on dual-energy CT-derived virtual non-contrast images through fully-automated 3D organ segmentation.
Jeon SK; Joo I; Park J; Yoo J
Radiol Med; 2024 Jun; ():. PubMed ID: 38869829
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
[TBL] [Abstract][Full Text] [Related]
12. NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson's disease using convolutional neural network.
Gaurav R; Valabrègue R; Yahia-Chérif L; Mangone G; Narayanan S; Arnulf I; Vidailhet M; Corvol JC; Lehéricy S
Neuroimage Clin; 2022; 36():103250. PubMed ID: 36451356
[TBL] [Abstract][Full Text] [Related]
13. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.
Imajo K; Toyoda H; Yasuda S; Suzuki Y; Sugimoto K; Kuroda H; Akita T; Tanaka J; Yasui Y; Tamaki N; Kurosaki M; Izumi N; Nakajima A; Kumada T
Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2533-2541.e7. PubMed ID: 34768008
[TBL] [Abstract][Full Text] [Related]
14. Real-time ultrasound-derived fat fraction in pediatric population: feasibility validation with MR-PDFF.
Zalcman M; Barth RA; Rubesova E
Pediatr Radiol; 2023 Nov; 53(12):2466-2475. PubMed ID: 37667050
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard.
Mu R; Xia YC; Zhu KY; Lu JY; Luo Q; Zhang L; Lin RK; Cai XB; Qu Y; Lu LG
J Dig Dis; 2023 Dec; 24(12):691-701. PubMed ID: 37994615
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Park SJ
Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
[TBL] [Abstract][Full Text] [Related]
17. Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease: comparison with a region of interest sampling method.
Zhang QH; Zhao Y; Tian SF; Xie LH; Chen LH; Chen AL; Wang N; Song QW; Zhang HN; Xie LZ; Shen ZW; Liu AL
Quant Imaging Med Surg; 2021 Jul; 11(7):2933-2942. PubMed ID: 34249624
[TBL] [Abstract][Full Text] [Related]
18. Marked difference in liver fat measured by histology
Qadri S; Vartiainen E; Lahelma M; Porthan K; Tang A; Idilman IS; Runge JH; Juuti A; Penttilä AK; Dabek J; Lehtimäki TE; Seppänen W; Arola J; Arkkila P; Stoker J; Karcaaltincaba M; Pavlides M; Loomba R; Sirlin CB; Tukiainen T; Yki-Järvinen H
JHEP Rep; 2024 Jan; 6(1):100928. PubMed ID: 38089550
[TBL] [Abstract][Full Text] [Related]
19. Cutoff Values for Diagnosing Hepatic Steatosis Using Contemporary MRI-Proton Density Fat Fraction Measuring Methods.
Park S; Kwon JH; Kim SY; Kang JH; Chung JI; Jang JK; Jang HY; Shim JH; Lee SS; Kim KW; Song GW
Korean J Radiol; 2022 Dec; 23(12):1260-1268. PubMed ID: 36447414
[TBL] [Abstract][Full Text] [Related]
20. Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.
Campo CA; Hernando D; Schubert T; Bookwalter CA; Pay AJV; Reeder SB
AJR Am J Roentgenol; 2017 Sep; 209(3):592-603. PubMed ID: 28705058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
